drugset / Trial / NCT00796575

Effects of Multiple Doses of CS-8080 in Healthy Volunteers

NCT00796575 ↗

Phase 1 Terminated 16 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purposes of this study are to assess the safety and measure the pharmacokinetics and pharmacodynamics of CS-8080 in healthy volunteers.

Timeline

Start
2008-11
Primary completion
2008-12
Completion
2008-12

Outcome

Outcome not reported

Stopped: “Safety concerns”

Drugs

EvaluationDrugModalityDoseRoute
Subject CS8080 Unknown 3 mg —
Subject CS8080 Unknown 10 mg —
Subject CS8080 Unknown 20 mg —

Indications

No indication recorded.